A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.
D000931:Antidotes / Q000008:administration & dosage*; D002945:Cisplatin / Q000009:adverse effects*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005978:Glutathione / Q000008:administration & dosage*; D006309:Hearing / Q000187:drug effects; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000931:Antidotes; D005978:Glutathione; D002945:Cisplatin